Evidence suggesting the 58-kDa acetaminophen binding protein is a preferential target for acetaminophen electrophile

Fundamental and Applied Toxicology

Volumn 32, Issue 1, 1996, Pages 79-86

  Hoivik, Debie J ^a   Manautou, José E ^a   Tveit, Ann ^a,b   Mankowski, Dayna C ^a,c   Khairallah, Edward A ^a   Cohen, Steven D ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b EXXONMOBIL UPSTREAM RESEARCH COMPANY   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; PARACETAMOL; TESTOSTERONE PROPIONATE;

ANIMAL EXPERIMENT; ARTICLE; COVALENT BOND; DRUG PROTEIN BINDING; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY; LIVER; MALE; MOUSE; NONHUMAN; SEX DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 26944496502     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1996.0109     Document Type: Article

References (41)

1. Bartolone, J. B., Sparks, K., Cohen, S. D., and Khairallah, E. A. (1987). Immunochemical detection of acetaminophen-bound liver proteins. Biochem. Pharmacol. 36, 1193-1196.
2. Bartolone, J. B., Birge, R. B., Sparks, K., Cohen, S. D., and Khairallah, E. A. (1988). Immunochemical analysis of acetaminophen covalent binding to proteins: Partial characterization of the major acetaminophen-binding liver proteins. Biochem. Pharmacol 37, 4763-4774.
3. Bartolone, J. B., Cohen, S. D., and Khairallah, E. A. (1989a). Immunohistochemical localization of acetaminophen-bound liver proteins. Fundam. Appl. Toxicol. 13, 859-862.
4. Bartolone, J. B., Beierschmitt, W. P., Birge, R. B., Emeigh Hart, S. G., Wyand, S., Cohen, S. D., and Khairallah, E. A. (1989b). Selective acetaminophen metabolite binding to hepatic and extrahepatic proteins: An in vivo and in vitro analysis. Toxicol. Appl. Pharmacol. 99, 240-249.
5. Bartolone, J. B., Birge, R. B., Bulera, S. J., Bruno, M. K., Nishanian, E. V., Cohen, S. D., and Khairallah, E. A. (1992). Purification, antibody production, and partial amino acid sequence of the 58-kDa acetaminophen-binding liver proteins. Toxicol. Appl. Pharmacol. 113, 19-29.
6. Beierschmitt, W. P., Brady, J. T., Bartolone, J. B., Wyand, D. S., Khairallah, E. A., and Cohen, S. D. (1989). Selective protein arylation and the age dependency of acetaminophen hepatotoxicity in mice. Toxicol. Appl. Pharmacol. 98, 517-529.
7. Birge, R. B., Bartolone, J. B., McCann, D. J., Mangold, J. B., Cohen, S. D., and Khairallah, E. A. (1989). Selective protein arylation of acetaminophen and 2,6-dimethylacetaminophen in cultured hepatocytes from phenobarbital-induced and uninduced mice: relationship to cytotoxicity. Biochem. Pharmacol. 38, 4429-4438.
8. Birge, R. B., Bartolone, J. B., Emeigh Hart, S. G., Nishanian, E. V., Tyson, C. A., Khairallah, E. A., and Cohen, S. D. (1990). Acetaminophen hepatotoxicity: Correspondence of selective protein arylation in human and mouse liver in vitro, in culture and in vivo. Toxicol. Appl. Pharmacol. 105, 472-482.
9. Birge, R. B., Bartolone, J. B., Cohen, S. D., Khairallah, E. A., and Smolin, L. A. (1991a). A comparison of proteins S-thiolated by glutathione to those arylated by acetaminophen. Biochem. Pharmacol. 42, S197-S207.
10. Birge, R. B., Bulera, S. J., Bartolone, J. B., Ginsberg, G. L., Cohen, S. D., and Khairallah, E. A. (1991b). The arylation of microsomal membrane proteins by acetaminophen is associated with the release of a 44-kDa acetaminophen-binding mouse liver protein complex into the cytosol. Toxicol. Appl. Pharmacol. 109, 443-454.
11. Boelsterli, U. A. (1993). Specific targets of covalent drug-protein interac-tions in hepatocytes and their toxicological significance in drug-induced liver injury. Drug Metab. Rev. 25, 395-451.
12. Boyd, E. M., and Bereczky, G. M. (1966). Liver necrosis from paracetamol. Br. J. Pharmacol. 26, 606-614.
13. Boyer, T. D., and Rouf, S. L. (1971). Acetaminophen induced hepatic necrosis and renal failure. J. Am. Med. Assoc. 218, 440-441.
14. Bruno, M. K., Cohen, S. D., and Khairallah, E. A. (1992). Selective alterations in the patterns of newly synthesized proteins by acetaminophen and its dimethylated anologues in primary cultures of mouse hepatocytes. Toxicol. Appl. Pharmacol. 112, 282-290.
15. Bulera, S. J., Birge, R. B., Cohen, S. D., and Khairallah, E. A. (1995). Identification of the mouse liver 44 kDa acetaminophen binding protein as a subunit of glutamine synthetase. Toxicol. Appl. Pharmacol. 134, 313-320.
16. Cummings, A. J., King, M. L., and Martin, B. K. (1967). A kinetic study of drug elimination: The excretion of paracetamol and its metabolites in man. Br. J. Pharmacol. 29, 150-157.
17. Emeigh Hart, S. G., Beierschmitt, W. P., Bartolone, J. B., Wyand, D. S., Khairallah, E. A., and Cohen, S. D. (1991). Evidence against deacetylation and for cytochrome P450-mediated activation in APAP-induced nephrotoxicity in the CD-1 mouse. Toxicol. Appl. Pharmacol. 107, 1-15.
18. Halmes, N. C., Hinson, J. A., and Pumford, N. R. (1994). Purification of a 67 kDa hepatic mitochondrial protein which covalently binds to a metabolite of acetaminophen. Toxicologist 14, 1687.
19. Hjelle, J. J., Hazelton, G. A., and Klaassen, C. D. (1985). Acetaminophen decreases adenosine 3′-phosphate 5′-phosphosulfate and uridine diphospate glucuronic acid in rat liver. Drug Metab. Dispos. 13, 35-41.
20. Hoivik, D. J., Manautou, J. E., Khairallah, E. A., and Cohen, S. D. (1995a). Is the 58 kDa acetaminophen binding protein (58-ABP) an electrophile scavenger? Toxicologist 15, 818.
21. Hoivik, D. J., Manautou, J. E., Tveit, A., Hart, S. G. E., Khairallah, E. A., and Cohen, S. D. (1995b). Gender-related differences in susceptibility to acetaminophen-induced protein arylation and nephrotoxicity in the CD-1 mouse. Toxicol. Appl. Pharmacol. 130, 257-271.
22. Hong, M., Cohen, S. D., and Khairallah, E. A. (1994). Translocation of the major cytosolic acetaminophen (APAP) protein adducts into the nucleus. Toxicologist 14, 1691.
23. Jeffery, W. H., and Lafferty, W. E. (1981). Acute renal failure after acetaminophen overdose: Report of two cases. Am. J. Hosp. Pharm. 38, 1355-1358.
24. Jollow, D. J., Mitchell, J. R., Potter, W. Z., Davis, D. C., Gillette, J. R., and Brodie, B. B. (1973). Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J. Pharmacol. Exp. Ther. 187, 195-202.
25. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature 227, 680-685.
26. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951). Protein measurement with the folin-phenol reagent. J. Biol. Chem. 193, 265-275.
27. Manautou, J. E., Hoivik, D. J., Tveit, A., Hart, S. G. E., Khairallah, E. A., and Cohen, S. D. (1994). Clofibrate pretreatment diminishes acetaminophen's selective covalent binding and hepatotoxicity. Toxicol. Appl. Pharmacol. 129, 252-263.
28. Manautou, J. E., Khairallah, E. A., and Cohen, S. D. (1995). Evidence for common binding of acetaminophen and bromobenzene to the 58 kDa acetaminophen binding protein. Toxicol. Environ. Health 46, 263-269.
29. McMurtry, R. J., Snodgrass, W. R., and Mitchell, J. R. (1978). Renal necrosis, glutathione depletion and covalent binding after acetaminophen. Toxicol. Appl. Pharmacol. 46, 87-100.
30. Mitchell, J. R., Jollow, D. J., Potter, W. Z., Davis, D., Gillette, J. R., and Brodie, B. B. (1973). Acetaminophen induced hepatic necrosis. I. Role of drug metabolism. J. Pharmacol. Exp. Ther. 187, 185-194.
31. Myers, T. G., Dietz, E. C., Anderson, N. L., Khairallah, E. A., Cohen, S. D., and Nelson, S. D. (1995). A comparative study of mouse liver proteins arylated by reactive metabolites of acetaminophen and its non-hepatotoxic regioisomer, 3′-hydroxyacetanilide. Chem. Res. Toxicol. 8, 403-413.
32. Navarro, C., Cohen, S. D., and Khairallah, E. A. (1994). Use of transfected Hepal-6 cells to distinguish the anti-proliferative and hepatotoxic effects of acetaminophen. Mol. Biol. Cell. 5, 17a.
33. Nelson, S. D., and Pearson, P. G. (1990). Covalent and noncovalent interactions in acute lethal cell injury caused by chemicals. Annu. Rev. Pharmacol. Toxicol. 30, 169-195.
34. Newton, J. F., Kuo, C. H., Gemborys, M. W., Mudge, G. H., and Hook, J. B. (1982). Nephrotoxicity of p-aminophenol, a metabolite of acetaminophen, in the Fisher 344 rat. Toxicol. Appl. Pharmacol. 65, 336-344.
35. Nishanian, E. V. (1989). Isolation and Partial Characterization of a Major Acetaminophen Binding Protein. Ph.D. dissertation, University of Connecticut.
36. Placke, M. E., Ginsberg, G. L., Wyand, D. S., and Cohen, S. D. (1987). Ultrastructural changes during acute acetaminophen-induced hepatotoxicity in the mouse: A time and dose study. Toxicol. Pathol. 15, 431-438.
37. Potter, W. Z., Thorgeirsson, S. S., Jollow, D. J., and Mitchell, J. R. (1974). Acetaminophen-induced hepatic necrosis. V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters. Pharmacology 12, 129-143.
38. Pumford, N. R., Martin, B. M., and Hinson, J. A. (1992). A metabolite of acetaminophen covalently binds to the 56 kDa selenium binding protein. Biochem. Biophys. Res. Commun. 182, 1348-1355.
39. Pumford, N. R., Halmes, N. C., Martin, B. M., and Hinson, J. A. (1994). Covalent binding to N-10-formyl tetrahydrofolate dehydrogenase following a hepatotoxic dose of acetaminophen. Toxicologist, 14, 1688.
40. Vecchiarelli, M. M., Tveit, A., Manautou, J. E., Khairallah, E. A., and Cohen, S. D. (1994). Discrimination among acetaminophen (APAP) hepatic protein targets: Mouse strain and APAP analog comparisons. Toxicologist 14, 1693.
41. Vermeulen, N. P. E., Bessems, J. G. M., and Van De Straat, R. (1992). Molecular aspects of paracetamol-induced hepatotoxicity and its mechanism-based prevention. Drug Metab. Rev. 24, 367-407.